Domainex, a UK-based drug discovery company, has raised £1.5m ($2m) to accelerate research from investors including University College London Business (UCLB).
The firm had a first close in December, which was also joined in participation by venture firm Bury Fitzwilliam-Lay and Partners and led by Longbow Capital. A second close is planned in April for the Cambridge, UK-based firm with Longbow Capital leading the round.
Longbow previously led a £718,000 round in Domainex in 2008, which was joined by YFM…
